Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Inno Biologics Sdn. Bhd Company Profile

20:05 EDT 20th April 2014 | BioPortfolio

Inno Biologics Sdn. Bhd., a contract manufacturer, operates a cGMP manufacturing facility for the production of biopharmaceutical API. It is the flagship biotech company of Inno Bio Ventures Sdn. Bhd., a Malaysian Ministry of Finance Incorporated Company with a close affiliation with Ministry of Science, Technology and Innovation of Malaysia.Our services cover all stages of the production of mammalian cell-based therapeutic proteins and monoclonal antibodies, from DNA recombination work and bioprocess development to cGMP manufacturing. Our reliable, rapid and cost-effective services will reduce your risks, costs and time investment so you can get your products on the market in a timely manner.

Location

Lot 1, Persiaran Negeri BBN, Putra Nilai
Nilai
Negeri Sembilan
71800
Malaysia

Contact

Phone: 6 06 799 6661
Fax: 6 06 799 6660
Email: info@innobiologics.com


News Articles [363 Associated News Articles listed on BioPortfolio]

Nuvilex's Provides Progress Update on Cell Cloning Being Performed by Inno Biologics

SILVER SPRING, Md., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, provi...

Nuvilex's Contractor, Inno Biologics, Employs Clone-Pix(TM) Technology in Cloning Cells for Future Clinical Trials

SILVER SPRING, Md., Dec. 11, 2013 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, annou...

Inno Biologics Employs Clone-Pix for Nuvilex

To obtain large numbers of cells for Nuvilex's pancreatic cancer trials

ShangPharma Biologics Head Mitchell Reff On Biologics R&D In China: An Interview With PharmAsia News

ShangPharma’s new Chief Biologic Officer Mitchell Reff discusses the company’s expansion into biologics and his views on biologics development in China.

Synthetic Biologics and Intrexon Corporation Initiate Development of Novel Biologics for a Subset of Patients Suffering from Irritable Bowel Syndrome (IBS)

ROCKVILLE, Md. and GERMANTOWN, Md., Dec. 9, 2013 /PRNewswire/ --Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of product candidates focused on the prevention and treatment of serious infe...

Synthetic Biologics: A Developer Of New Biologics Focused On Serious Infections

Following a failed drug, a company retrenches and reinvents itself as a developer of new biologics with novel mechanisms focused on serious infections and other diseases.

Mass Spectrometry System for Biologics Characterization

Developing new life-saving drugs and improving the efficacy and quality of existing therapeutic biologics drive the demand for innovation in the biopharmaceutical industry. To address this need, AB Sc...

Cobra Biologics and BioCancell Announce Agreement to Manufacture Promising Cancer Therapy Drug (News)

03 March 2014: Keele, UK - Cobra Biologics, a leading contract manufacturer of clinical and commercial scale biologics and pharmaceuticals, and targeted cancer therapy company BioCancell have ...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [70 Associated PubMed Articles listed on BioPortfolio]

Factors associated with withdrawal of the anti-TNFα biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry.

To study the factors associated with withdrawal of the and tumor necrosis factor alpha (anti-TNFα) biologics in the treatment of rheumatic diseases.

Evaluation of a multiplex ELISA for autoantibody profiling in patients with autoimmune connective tissue diseases.

The performance of immunoassays for the detection of autoantibodies is of critical importance in the diagnosis and assessment of patients with autoimmune connective tissue diseases (ACTD). Our objecti...

Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis.

Biosimilars are copies of biological reference medicines. Unlike generics (copies of chemical molecules), biologics are complex, expensive and complicated to produce. The knowledge of the factors affe...

A170: Neoplasms in Pediatric Patients with Rheumatic Diseases Exposed to Biologics-A Quarternary Centre's Experience.

Biologic therapies have revolutionized the management of rheumatic diseases of childhood. However, these medications are associated with adverse effects including the possible development of neoplasms...

Advances in treating psoriasis.

Psoriasis is a T helper (Th)17/Th1-mediated autoimmune disease affecting the skin and joints. So far, distinct traditional oral compounds and modern biologics have been approved in most countries for...

Clinical Trials [23 Associated Clinical Trials listed on BioPortfolio]

INNO-105 in Patients With Solid Tumors

The safety, tolerability and pharmacokinetics of INNO-105, an investigational anticancer drug, are being studied in patients with solid tumors.

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health...

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs)...

Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

Biologics are routinely used for the treatment of rheumatoid arthritis (RA). Adalimumab is a human monoclonal antibody that inhibit the Tumor Necrosis Factor alpha (TNF-alpha). Identificat...

Companies [184 Associated Companies listed on BioPortfolio]

Inno Biologics Sdn. Bhd

Inno Biologics Sdn. Bhd., a contract manufacturer, operates a cGMP manufacturing facility for the production of biopharmaceutical API. It is the flagship biotech company of Inno Bio Ventures Sdn. Bhd....

inno GmbH

inno group is a strategic management consulting company located in Germany, France, Austria, Sweden and with a representation in Russia.inno group designs and implements innovation strategies for Regi...

Innocorp, ltd.

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic...

More Information about "Inno Biologics Sdn. Bhd" on BioPortfolio

We have published hundreds of Inno Biologics Sdn. Bhd news stories on BioPortfolio along with dozens of Inno Biologics Sdn. Bhd Clinical Trials and PubMed Articles about Inno Biologics Sdn. Bhd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inno Biologics Sdn. Bhd Companies in our database. You can also find out about relevant Inno Biologics Sdn. Bhd Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement